John Hood bags $90M for his quest to get fedratinib OK’d by FDA and catapult into the market
It took 18 months for John Hood to get the late-stage drug fedratinib back from Sanofi, assemble a small crew of execs for his startup …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
